ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Varmus to NCAB: Budgetary “Haircuts” No Longer Sufficient to Cope With Fiscal Pressure

September 16, 2011

In Brief: BMS Chemistry Awards to Honor Fu, Wood; Groshow Joins NCI; Bowman Moves to TJU

January 15, 1999

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980

NCI-Approved Cancer Center, Cooperative Group Trials

April 27, 2007

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976